CIK 0001326732 · Accelerated filer
Xencor Inc
Sign in to watch- Ticker
- XNCR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 201622502
- Phone
- 626-305-5900
- Business address
- 465 N. HALSTEAD ST., SUITE 200, PASADENA, CA, 91107
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,591,617
- in 2 filings
Net −$3,591,617. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-16 | Montgomery Alan Bruce Director | Grant or award | +10,302 | 25,849 | ||
| 2026-06-16 | Montgomery Alan Bruce Director | Grant or award · Stock Option (Right to Buy) | +20,604 | 20,604 | ||
| 2026-06-16 | RANIERI RICHARD J Director | Grant or award | +10,302 | 24,011 | ||
| 2026-06-16 | RANIERI RICHARD J Director | Grant or award · Stock Option (Right to Buy) | +20,604 | 20,604 | ||
| 2026-06-16 | SIMPSON TODD E Director | Grant or award | +10,302 | 23,988 | ||
| 2026-06-16 | SIMPSON TODD E Director | Grant or award · Stock Option (Right to Buy) | +20,604 | 20,604 | ||
| 2026-06-16 | GORMAN KEVIN CHARLES Director | Grant or award | +10,302 | 21,680 | ||
| 2026-06-16 | GORMAN KEVIN CHARLES Director | Grant or award · Stock Option (Right to Buy) | +20,604 | 20,604 | ||
| 2026-06-15 | GUSTAFSON KURT A Director | Sale 10b5-1 | −5,474 | $12.31 | $67K | 14,709 |
| 2026-06-15 | Montgomery Alan Bruce Director | Sale 10b5-1 | −5,064 | $12.31 | $62K | 15,547 |
| 2026-06-15 | RANIERI RICHARD J Director | Sale 10b5-1 | −5,474 | $12.31 | $67K | 13,709 |
| 2026-06-15 | GORMAN KEVIN CHARLES Director | Sale 10b5-1 | −7,527 | $12.31 | $93K | 11,378 |
| 2026-04-10 | Cornelissen Bart Jan SR. VICE PRESIDENT & CFO | Sale | −3,499 | $12.29 | $43K | 75,898 |
| 2026-03-06 | Eckert Celia SVP, GENERAL COUNSEL | Sale | −1,767 | $11.02 | $19K | 76,918 |
| 2026-03-06 | Desjarlais John R SR. VICE PRESIDENT & CSO | Sale | −2,502 | $11.02 | $28K | 263,831 |
| 2026-03-06 | Dahiyat Bassil I PRESIDENT & CEO | Sale | −6,606 | $11.02 | $73K | 546,316 |
| 2026-03-05 | Cornelissen Bart Jan SR. VICE PRESIDENT & CFO | Sale | −2,517 | $11.25 | $28K | 79,397 |
| 2026-03-05 | Eckert Celia SVP, GENERAL COUNSEL | Sale | −3,244 | $11.25 | $36K | 78,685 |
| 2026-03-05 | Desjarlais John R SR. VICE PRESIDENT & CSO | Sale | −4,118 | $11.25 | $46K | 266,333 |
| 2026-03-05 | Dahiyat Bassil I PRESIDENT & CEO | Sale | −14,870 | $11.25 | $167K | 552,922 |
Page 2 of 11 · 211 trades